CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors - Concepedia

Concepedia

Publication | Open Access

CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors

DOI Full Paper Access

16

Citations

34

References

2024

Year

Jianghua Wang, Xiaoting Li, Guanxi Xiao, Jayesh Desai, Sophia Frentzas, Zhongmin Maxwell Wang, Yu Xia, Baiyong Li

Cancer Immunology Immunotherapy

Abstract

Our findings demonstrate that CD74 is a promising predictive biomarker for AK104 therapeutic response in advanced solid tumors. Trial registration number NCT03261011.

References

	Year	Citations

Page 1